BTG plc (BCG) 2015年年度报告「LSE」.pdf

1、 Building a leading healthcare businessBTG plc Annual Report and Accounts 2015About BTGAt BTG we are focused on bringingto market innovative products in specialist areas of medicine to serve doctors and patients better.Our growing portfolio of Interventional Medicine products is designed to advance

2、the treatment of liver tumours,advanced emphysema,severe blood clots and varicose veins,while our Specialty Pharmaceuticals portfolio offers antidotes that alleviate toxicity and treat rare conditions.Healthcare is constantly evolving so BTG never stands still.Inspired by a deep understanding of our

3、 customers needs,were working to meaningfully improve the lives of patients and their healthcare experience.Our competitive advantage is our dedication to finding smart,often unconventional solutions to complex medical problems.Many of our products combine medicines,device technology and new techniq

4、ues in order to deliver more targeted treatments.We also invest in the clinical evidence that helps demonstrate the value of our products to doctors,patients and healthcare systems.Whether developed in our own labs or in partnership with clinicians,academics and other companies,we believe passionate

5、ly that medical innovation has the power to improve human health.Imagine where we can go.BTG plc Annual Report and Accounts 2015ContentsStrategic ReportAt a glance 02Business model 03Chairmans statement 04Chief Executive Officers review 06Delivering our growth strategy:Geographic expansion 08Deliver

6、ing our growth strategy:Indication expansion 10Delivering our growth strategy:Product innovation 12Delivering our growth strategy:Expanding our business:PneumRx 14Our objectives 16Group financial review 20Market overview 24Our business model 26Corporate responsibility 30Risk management and principal